Merck Czech Republic's net debt stood at CZK -25.1 mil and accounted for -3.73% of equity at the end of 2017. The ratio is up 0.620 pp compared to the previous year.
Historically, the firm’s net debt to equity reached a high of 230% in 2008 and a low of -7.82% in 2003 between 2002 and 2017. The average for the last five years was 8.06%.
Net debt to EBITDA was calculated at -0.345x at the end of the year. That is down from 1.39x seen in 2012. The ratio reached a high of 26.1x in 2008 and a low of -0.445x in 2016.
The company’s cost of funding amounted to in 2017, down which is above the 5-year of 27.1%. Funding costs have “eaten” some 9.49% of the operating profit generated in 2019.
You can see all the company’s data at Merck Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
